Aerie Pharma (AERI) Tops Q2 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. SPY
7. META
8. HOOD
9. INTC
10. JBLU

Go back to Aerie Pharma (AERI) Tops Q2 EPS by 11c

Aerie Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Business Update

August 5, 2015 4:05 PM EDT

- Company Expects Efficacy Results from RhopressaTM Rocket 2 Trial in September 2015 -

Conference Call and Webcast Today, August 5, at 5:00 p.m. ET

IRVINE, Calif.--(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today reported financial results for the second quarter ended June 30, 2015 along with a general business update.

This Smart News Release features multimedia. View the full release... More